Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions. As a member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for over 40 years, using human genetic information to develop novel medicines. The company is known for its strong scientific foundation, innovative research, and commitment to transforming patient care in areas such as oncology, immunology, neuroscience, and ophthalmology.
Serves as the primary center for research, development, corporate operations, and U.S. commercial activities.
Sprawling, modern campus with state-of-the-art research laboratories, collaborative workspaces, advanced manufacturing capabilities, and employee amenities reflecting its focus on innovation and well-being.
Highly innovative, science-driven, collaborative, and mission-focused, emphasizing breakthrough research and patient impact. Strong emphasis on diversity, inclusion, and employee development.
Considered the birthplace of the biotechnology industry. It remains a major hub for R&D within the Roche Group and a significant contributor to the San Francisco Bay Area's life sciences ecosystem.
While Genentech's primary operations are in the United States, as a member of the Roche Group, its innovations and medicines reach patients globally. Genentech supports global functions through its world-class research and early development (gRED) and product development capabilities based in South San Francisco. Its U.S. manufacturing sites in California and Oregon contribute to Roche's global supply chain. Commercialization outside the U.S. is typically handled by Roche's global network, ensuring that Genentech's discoveries benefit patients worldwide.
1 DNA Way
South San Francisco
California
USA
Address: 1 Antibody Way, Hillsboro, OR 97124, USA
Supports large-scale production of therapeutics for the U.S. and global markets, playing a key role in the company's supply chain and manufacturing excellence.
Address: 1000 New Horizons Way, Vacaville, CA 95688, USA
Ensures large-scale, reliable supply of critical medicines for patients worldwide, representing a significant manufacturing capacity for the Roche Group.
Address: 1 Genentech Way, Oceanside, CA 92056, USA
Contributes to Genentech's diverse manufacturing network, ensuring production capabilities for various product types and supporting both clinical trial and commercial supply needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genentech' leadership includes:
Genentech has been backed by several prominent investors over the years, including:
Genentech's executive team saw a key leadership appointment in the last 12 months with the naming of a new Head of gRED. Overall, the top leadership structure aims for stability combined with strategic enhancements to drive its mission.
Discover the tools Genentech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Genentech commonly uses specific email formats for its employees. The most frequently observed patterns are [lastname][firstinitial]@gene.com or [firstname].[lastname]@gene.com. These formats allow for systematic communication within the organization and with external partners.
lastnamef@gene.com or firstname.lastname@gene.com
Format
doej@gene.com or jane.doe@gene.com
Example
85%
Success rate
Genentech Press Release • May 20, 2024
New Phase III data presented at the 2024 European Hematology Association Congress show subcutaneous crovalimab was well-tolerated and effectively controlled disease in children and adolescents with PNH....more
Genentech Press Release • February 16, 2024
XOLAIR is the first and only FDA-approved medicine to reduce allergic reactions to multiple foods after accidental exposure. This approval marks a significant advancement for people living with food allergies....more
Genentech Press Release • February 3, 2024
New data presented at Angiogenesis, Exudation, and Degeneration 2024 showed Vabysmo continues to demonstrate robust vision gains and drying of retinal fluid in RVO, with extended dosing intervals up to every four months for eligible patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genentech, are just a search away.